BRAIN Biotech AG

€2.62As of Sun 8 Nov 2026, 12:00 UTC
XETRA:BNNMaterials
Country Germany
PE (Fwd) •••
TSR 10Y CAGR (16.26%)
Div yield —
ROE —
Specialty Chemicals
Beta (5Y) 0.60
PE TTM —
TSR TTM 19.63%
Mkt cap €57.24M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
€2.66
1.37%
(93.75%)
Hold 5|5|4|9|10
1Q26
2Q26
3Q26
4Q26
Earnings per share€
0.04
0.04
0.04
0.04
33.14%
16.20%
8.91%
(1.35%)
Revenue€M
2.431
2.377
2.401
2.508
2.03%
1.98%
(0.01%)
3.89%
Peers (US$64.27M)
Cap (US$)
PE
282.5M
98.91x
149.6M
14.05x
105.7M
11.56x
64.01M
17.56x
Capital
TTM
5Y
10Y
Leveragex
0.374
0.285
0.273
EBIT/Intx
1.219
0.064
0.066
Own earn%
147.50
(67.86)
(96.63)
Sh yield%
22.20
32.67
35.88
Owners
Insiders/Inst%
6.31
81.61
Short interest%
5.49
SBC / revenue%
4.64
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
2–6
$1 testx
−1.0
Incr. ROIC%
6